BreezeBio

About BreezeBio

BreezeBio is a biotechnology company focused on solving the challenge of targeted delivery of genetic medicines. Using their proprietary NanoGalaxy platform, they aim to enable precise delivery of genetic payloads to specific cells and tissues, particularly to restore immune balance in autoimmune diseases and offer durable cures.

Products & Services

NanoGalaxy Platform:A programmable delivery platform for genetic medicines, designed to target specific cells and tissues with non-immunogenic nanoparticles.

BRZ-101:A lead program for Type 1 Diabetes, featuring HNP-mRNA immune modulation therapy to induce antigen-specific immune tolerance.

Pipeline Therapies:Multiple programs targeting autoimmune diseases and oncology through precision delivery of genetic medicines.

Specialties

Targeted Delivery of Genetic Medicines Autoimmune Disease Therapies Immune Modulation Non-Immunogenic Nanoparticles Oncology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2026-02-25 FD: 2026-02-25	13 investors

Series B Latest

2026-02-25

$60.0M

13 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kunwoo Lee

Chief Executive Officer & Co-founder

H

Hyo Min Park

Chief Operating Officer & Co-founder

N

Niren Murthy

Co-founder

J

Jennifer Doudna

Nobel Laureate

D

David Schaffer

Independent Director

J

J Rodrigo Mora

Chief Scientific Officer

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

BreezeBio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised